Orzit S 500mg/250mg Injection
Marketer
Age Biotech
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Orzit S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration should always be under a doctor's guidance; adhere strictly to the prescribed schedule. Complete the full course of treatment, even with symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Severe or worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your physician of all current medications, and pregnant or nursing individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, a nutritious diet, and ample hydration are crucial for optimal recovery. Your doctor may order tests to monitor the medication's impact.
Uses of Orzit S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Orzit S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Orzit S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Orzit S 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Orzit S 500mg/250mg Injection works:
Orzit S Injection, containing 500mg Ceftriaxone and 250mg Sulbactam, leverages a dual-action approach to combat bacterial infections. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this by neutralizing bacterial defenses, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concurrent use of Orzit S 500mg/250mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Administration of Orzit S 500mg/250mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The injection Orzit S 500mg/250mg requires careful administration while breastfeeding. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Orzit S 500mg/250mg Injection can cause drowsiness, blurred vision, and dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Orzit S 500mg/250mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The 500mg/250mg Orzit S Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for the 500mg/250mg Orzit S Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Orzit S 500mg/250mg Injection :
Should you forget a scheduled dose of Orzit S 500mg/250mg Injection, seek advice from your physician.
Facts to Know About Orzit S 500mg/250mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Antimicrobial agents |
3,018 People bought this recently